The medication may still be fine, or it may have degraded past the point of effectiveness
It works quickly, surpassing diet and exercise alone
Bimagrumab has been studied in over 1,000 patients across multiple indications (IBM, sarcopenia, obesity)
You don't reach $1.6 billion in first-year revenue with a product that doesn't work
Sawicka AK, Renzi G, Olek RA. The bright and the dark sides of L-carnitine supplementation: a systematic review. J Int Soc Sports Nutr. 2020 Sep 21;17(1):49. doi: 10.1186/s12970-020-00377-2. PMID: 32958033; PMCID: PMC7507632
How ongoing care shapes GLP-1 outcomes 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more